Bristol-Myers Squibb (BMY) stock price, revenue, and financials

Bristol-Myers Squibb market cap is $145 b, and annual revenue was $26.15 b in FY 2019

$145 B

BMY Mkt cap, 15-May-2020

$10.8 B

Bristol-Myers Squibb Revenue Q1, 2020
Bristol-Myers Squibb Gross profit (Q1, 2020)7.1 B
Bristol-Myers Squibb Gross profit margin (Q1, 2020), %66%
Bristol-Myers Squibb Net income (Q1, 2020)-766 M
Bristol-Myers Squibb Cash, 31-Mar-202015.8 B
Bristol-Myers Squibb EV175.9 B

Bristol-Myers Squibb Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

16.4b15.9b16.6b19.4b20.8b22.6b26.1b

Revenue growth, %

(3%)4%17%7%9%

Cost of goods sold

4.6b3.9b3.9b4.9b6.1b8.1b

Gross profit

11.8b11.9b12.7b14.5b14.7b18.1b

Gross profit Margin, %

72%75%76%75%71%69%

R&D expense

3.7b4.5b5.9b4.9b6.4b6.3b6.1b

General and administrative expense

4.1b4.1b4.8b4.9b4.9b

Operating expense total

7.8b8.6b10.8b9.9b15.6b16.6b11.0b

Pre tax profit

2.9b2.4b2.1b5.9b5.1b6.0b5.0b

Income tax expense

311.0m352.0m446.0m1.4b4.2b1.0b1.5b

Net Income

2.6b2.0b1.6b4.5b975.0m4.9b3.4b

Bristol-Myers Squibb Balance Sheet

Annual

USDFY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

5.0b5.8b1.7b3.6b5.6b2.4b4.2b5.4b6.9b12.3b

Accounts Receivable

2.0b2.3b1.7b6.3b6.0b7.7b

Prepaid Expenses

252.0m258.0m355.0m576.0m1.1b2.0b

Inventories

1.2b1.4b1.7b1.5b1.6b1.2b1.2b1.2b1.2b4.3b

Current Assets

13.3b15.3b9.5b18.9b14.6b10.4b13.7b14.9b17.2b29.4b

PP&E

4.7b4.5b5.3b5.0b5.0b6.3b

Goodwill

5.2b5.6b7.6b7.1b7.0b6.9b6.9b6.9b6.5b22.5b

Total Assets

31.1b33.0b35.9b38.6b33.7b31.7b33.7b33.6b35.0b129.9b

Accounts Payable

2.0b2.6b2.2b2.6b2.5b1.6b1.7b2.2b1.9b2.4b

Dividends Payable

575.0m597.0m606.0m634.0m645.0m655.0m

Short-term debt

117.0m115.0m648.0m359.0m590.0m139.0m992.0m987.0m1.7b3.3b

Current Liabilities

6.7b7.8b8.3b12.4b8.5b8.0b8.8b9.6b10.7b18.3b

Long-term debt

5.3b5.4b6.6b8.0b7.2b6.6b5.7b7.0b5.6b44.1b

Total Debt

5.4b5.5b7.2b8.3b7.8b6.7b6.7b7.0b7.3b47.4b

Total Liabilities

15.4b17.1b22.3b21.7b20.9b78.2b

Common Stock

220.0m220.0m221.0m221.0m221.0m292.0m

Preferred Stock

Additional Paid-in Capital

3.7b3.1b2.7b1.9b2.1b43.7b

Retained Earnings

31.6b33.1b32.7b33.0b32.5b31.6b33.5b31.2b34.1b34.5b

Total Equity

15.6b15.9b13.6b15.2b15.0b14.4b16.3b11.8b14.1b51.7b

Debt to Equity Ratio

0.5 x0.5 x0.5 x0.4 x0.6 x

Debt to Assets Ratio

0.2 x0.2 x0.2 x0.2 x0.2 x

Financial Leverage

2 x2.1 x2.6 x2.5 x2.3 x2.2 x2.1 x2.8 x2.5 x2.5 x

Quarterly

USDQ1, 2010Q2, 2010Q3, 2010Q1, 2011Q2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Cash

5.1b5.9b7.6b3.4b3.7b4.5b2.3b2.8b1.5b1.4b1.8b1.8b5.2b4.3b4.9b6.3b4.2b4.0b2.6b2.9b3.4b3.9b3.5b4.6b5.3b5.0b5.4b7.3b28.4b30.5b15.8b

Accounts Receivable

3.5b1.8b2.0b2.0b2.1b2.2b2.3b1.6b1.7b1.8b1.9b3.7b3.3b3.3b3.3b3.5b3.7b3.9b5.0b5.6b5.6b5.5b5.8b5.9b5.7b5.6b5.9b5.7b5.7b5.5b8.3b

Prepaid Expenses

268.0m296.0m292.0m451.0m420.0m356.0m500.0m455.0m423.0m616.0m536.0m556.0m538.0m512.0m482.0m538.0m502.0m529.0m615.0m588.0m565.0m628.0m820.0m754.0m965.0m998.0m886.0m1.3b1.4b947.0m

Inventories

1.3b1.3b1.4b1.3b1.5b1.4b1.5b1.5b1.7b1.8b1.8b1.6b1.7b1.7b1.6b1.4b1.3b1.1b1.3b1.4b1.5b1.4b1.2b1.3b1.2b1.2b1.3b1.3b1.3b1.2b2.8b

Current Assets

12.5b13.0b14.4b13.3b14.8b14.9b11.8b11.0b9.3b10.1b10.5b10.6b14.0b14.1b14.2b14.9b13.1b12.9b11.2b12.3b13.2b13.6b14.3b15.0b14.6b13.9b14.9b17.1b37.7b40.2b31.9b

PP&E

4.8b4.7b4.7b4.6b4.6b4.5b4.5b4.5b5.3b5.3b5.2b5.2b4.5b4.4b4.4b4.3b4.4b4.2b4.5b4.6b4.8b5.0b4.9b5.0b5.1b5.1b5.1b5.0b4.8b4.8b6.1b

Goodwill

5.2b5.2b5.2b5.2b5.2b5.6b6.8b6.8b7.5b7.6b7.6b7.6b7.0b7.0b7.0b7.0b7.0b7.0b6.9b6.9b6.9b6.9b6.9b6.9b6.9b6.7b6.7b6.5b6.5b6.5b22.5b

Total Assets

30.8b31.1b31.9b30.9b31.8b32.0b32.4b31.7b36.0b36.0b36.3b36.8b33.4b33.5b33.5b33.6b32.0b31.8b31.9b32.8b33.7b32.9b33.4b34.0b33.1b32.6b33.7b34.8b55.2b57.4b129.3b

Accounts Payable

1.8b1.7b1.7b2.0b2.4b2.3b2.4b2.1b2.1b2.1b2.3b2.5b2.5b2.4b2.6b2.3b1.8b1.2b1.5b1.5b1.4b1.5b1.6b1.7b1.7b1.9b1.8b2.0b2.0b1.9b3.1b

Dividends Payable

554.0m556.0m556.0m578.0m579.0m578.0m593.0m598.0m596.0m601.0m606.0m611.0m619.0m621.0m623.0m633.0m634.0m636.0m

Short-term debt

208.0m290.0m243.0m135.0m187.0m182.0m145.0m236.0m619.0m658.0m680.0m680.0m281.0m365.0m401.0m330.0m755.0m642.0m106.0m155.0m990.0m1.2b1.3b1.5b1.9b1.7b1.6b381.0m545.0m569.0m3.9b

Current Liabilities

6.0b5.9b6.3b6.8b7.4b7.3b7.2b7.0b8.2b8.4b8.4b8.3b7.5b7.8b8.1b7.7b7.4b7.2b7.6b7.9b9.0b8.5b9.0b9.4b9.6b9.9b9.7b8.8b9.7b10.5b19.2b

Long-term debt

6.1b6.2b6.5b5.3b5.3b5.4b5.3b5.2b6.6b6.5b6.4b6.5b7.4b7.4b7.3b7.1b6.6b6.6b6.6b6.6b5.8b7.2b6.9b7.0b5.8b5.7b5.7b5.6b24.4b24.4b42.8b

Total Debt

6.3b6.5b6.7b5.4b5.5b5.6b5.4b5.4b7.2b7.2b7.1b7.2b7.6b7.7b7.7b7.5b7.4b7.3b6.7b6.7b6.8b7.2b6.9b7.0b5.8b5.7b5.7b5.6b24.4b24.4b46.7b

Total Liabilities

15.5b15.5b16.0b15.0b15.7b15.6b16.2b15.9b22.1b22.3b21.9b22.1b17.9b18.1b18.2b17.9b16.7b16.5b17.3b17.8b17.9b18.4b18.6b19.1b20.2b20.2b20.0b19.5b39.0b39.7b79.3b

Common Stock

220.0m220.0m220.0m220.0m220.0m220.0m221.0m221.0m221.0m221.0m221.0m221.0m221.0m221.0m221.0m221.0m221.0m221.0m221.0m221.0m221.0m221.0m221.0m221.0m221.0m221.0m221.0m221.0m221.0m221.0m292.0m

Preferred Stock

Additional Paid-in Capital

3.7b3.7b3.7b3.4b3.3b3.2b2.8b2.8b2.7b2.1b2.0b2.0b1.4b1.5b1.5b1.3b1.4b1.4b1.5b1.6b1.7b1.3b1.8b1.8b1.9b2.0b2.0b2.1b2.2b2.2b43.3b

Retained Earnings

30.9b31.3b31.7b32.1b32.4b32.8b33.6b33.7b32.4b32.8b32.7b32.8b33.3b33.0b33.1b33.1b32.4b32.4b32.2b32.7b33.3b33.7b33.9b34.1b32.3b32.0b33.3b35.1b35.9b36.6b32.7b

Total Equity

15.2b15.6b15.9b15.9b16.1b16.4b16.2b15.8b13.9b13.7b14.4b14.7b15.5b15.4b15.2b15.7b15.3b15.3b14.6b15.1b15.8b14.5b14.8b14.9b12.9b12.4b13.8b15.3b16.2b17.8b50.0b

Debt to Equity Ratio

0.5 x0.5 x0.5 x0.5 x0.5 x0.5 x0.4 x0.4 x0.5 x0.5 x0.5 x0.4 x0.5 x0.4 x0.4 x1.5 x1.4 x

Debt to Assets Ratio

0.2 x0.2 x0.2 x0.2 x0.2 x0.2 x0.2 x0.2 x0.2 x0.2 x0.2 x0.2 x0.2 x0.2 x0.2 x0.4 x0.4 x

Financial Leverage

2 x2 x2 x1.9 x2 x1.9 x2 x2 x2.6 x2.6 x2.5 x2.5 x2.2 x2.2 x2.2 x2.1 x2.1 x2.1 x2.2 x2.2 x2.1 x2.3 x2.3 x2.3 x2.6 x2.6 x2.5 x2.3 x3.4 x3.2 x2.6 x

Bristol-Myers Squibb Cash Flow

Annual

USDFY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

3.1b3.7b2.0b2.6b2.0b1.6b4.5b975.0m4.9b3.5b

Depreciation and Amortization

473.0m448.0m681.0m789.0m637.0m1.7b

Accounts Receivable

(270.0m)(220.0m)648.0m(431.0m)(429.0m)752.0m

Inventories

156.0m(193.0m)(103.0m)(45.0m)(254.0m)97.0m(152.0m)(29.0m)(216.0m)463.0m

Accounts Payable

315.0m593.0m(232.0m)412.0m(44.0m)(919.0m)104.0m320.0m(59.0m)229.0m

Cash From Operating Activities

4.5b4.8b6.9b3.5b3.1b1.8b2.9b5.3b5.9b8.1b

Purchases of PP&E

(424.0m)(367.0m)(548.0m)(1.1b)(951.0m)(836.0m)

Capital Expenditures

(820.0m)(1.2b)

Cash From Investing Activities

(3.8b)(1.4b)(6.7b)(572.0m)1.2b(1.6b)1.5b(66.0m)(874.0m)(9.8b)

Short-term Borrowings

33.0m1.0m(49.0m)

Long-term Borrowings

(936.0m)(78.0m)(2.1b)(597.0m)(676.0m)(2.0b)(15.0m)(1.2b)(5.0m)(9.3b)

Dividends Paid

(2.2b)(2.3b)(2.3b)(2.6b)(2.6b)(2.7b)

Cash From Financing Activities

(3.3b)(2.7b)(4.3b)(1.1b)(2.4b)(3.4b)(2.4b)(4.1b)(3.5b)7.6b

Net Change in Cash

(2.6b)743.0m(4.1b)1.2b1.5b5.9b

Interest Paid

178.0m171.0m241.0m

Income Taxes Paid

672.0m597.0m676.0m

Free Cash Flow

2.7b4.1b

Quarterly

USDQ1, 2010Q2, 2010Q3, 2010Q1, 2011Q2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Net Income

1.1b1.7b2.6b986.0m1.9b2.9b1.1b1.7b1.0b609.0m1.1b1.8b936.0m1.3b2.0b1.2b1.1b1.8b1.2b2.4b3.6b1.5b2.4b3.3b1.5b1.9b3.8b1.7b3.2b4.5b(766.0m)

Depreciation and Amortization

187.0m246.0m348.0m117.0m228.0m333.0m85.0m175.0m482.0m213.0m402.0m582.0m137.0m252.0m364.0m104.0m195.0m300.0m65.0m155.0m260.0m240.0m404.0m592.0m143.0m300.0m465.0m223.0m443.0m510.0m2.6b

Accounts Receivable

(309.0m)54.0m122.0m(91.0m)(328.0m)(152.0m)(108.0m)544.0m643.0m(318.0m)(404.0m)(563.0m)(55.0m)(31.0m)(66.0m)(91.0m)(267.0m)(586.0m)(424.0m)(852.0m)(896.0m)(246.0m)(454.0m)(539.0m)219.0m112.0m(222.0m)236.0m307.0m434.0m(743.0m)

Inventories

25.0m(12.0m)37.0m(84.0m)(246.0m)(150.0m)(68.0m)(170.0m)(135.0m)(163.0m)(173.0m)(8.0m)(144.0m)(157.0m)(162.0m)51.0m162.0m231.0m(44.0m)(111.0m)(107.0m)(71.0m)(58.0m)7.0m(4.0m)(122.0m)(152.0m)35.0m28.0m(7.0m)1.4b

Accounts Payable

119.0m54.0m77.0m62.0m412.0m309.0m32.0m(222.0m)(321.0m)(53.0m)203.0m301.0m(12.0m)(112.0m)63.0m(83.0m)(618.0m)(1.2b)(77.0m)(36.0m)(142.0m)(114.0m)(85.0m)63.0m(241.0m)(101.0m)(186.0m)136.0m156.0m48.0m703.0m

Cash From Operating Activities

464.0m1.5b2.9b481.0m1.6b3.3b387.0m1.5b6.1b(428.0m)1.1b2.1b617.0m1.7b2.6b626.0m697.0m1.2b(386.0m)25.0m1.4b861.0m2.4b4.2b1.2b2.2b3.5b1.4b3.5b6.0b3.9b

Purchases of PP&E

(129.0m)(210.0m)(299.0m)(75.0m)(149.0m)(233.0m)(123.0m)(236.0m)(373.0m)(115.0m)(213.0m)(337.0m)(118.0m)(228.0m)(335.0m)(136.0m)(301.0m)(535.0m)(242.0m)(503.0m)(844.0m)(291.0m)(539.0m)(801.0m)(239.0m)(437.0m)(661.0m)(204.0m)(395.0m)(585.0m)(186.0m)

Cash From Investing Activities

(2.5b)(2.3b)(1.3b)(1.4b)(1.8b)(1.9b)(3.0b)(2.8b)(7.0b)161.0m218.0m(257.0m)2.2b701.0m865.0m754.0m(526.0m)(588.0m)1.4b1.8b1.5b(203.0m)(1.2b)(1.1b)(43.0m)(391.0m)(538.0m)1.1b1.8b2.3b653.0m

Short-term Borrowings

(61.0m)(12.0m)(18.0m)(70.0m)(67.0m)(30.0m)(121.0m)(20.0m)(551.0m)79.0m

Long-term Borrowings

(54.0m)(78.0m)(78.0m)(109.0m)(109.0m)(2.1b)(597.0m)(676.0m)(676.0m)(676.0m)(2.0b)(2.0b)(474.0m)(1.2b)(5.0m)(5.0m)(1.2b)(1.3b)(1.3b)

Dividends Paid

(551.0m)(1.1b)(1.7b)(565.0m)(1.1b)(1.7b)(579.0m)(1.2b)(1.7b)(580.0m)(1.2b)(1.7b)(605.0m)(1.2b)(1.8b)(623.0m)(1.2b)(1.9b)(641.0m)(1.3b)(1.9b)(655.0m)(1.3b)(1.9b)(653.0m)(1.3b)(2.0b)(669.0m)(1.3b)(2.0b)(1.0b)

Cash From Financing Activities

(486.0m)(981.0m)(1.7b)(692.0m)(1.2b)(1.9b)(836.0m)(1.7b)(3.4b)(44.0m)(1.2b)(1.8b)(1.2b)(1.7b)(2.2b)(682.0m)(1.6b)(2.3b)(792.0m)(1.3b)(1.9b)(1.0b)(2.0b)(2.7b)(1.2b)(2.2b)(3.0b)(2.0b)16.2b15.3b(1.1b)

Net Change in Cash

(2.5b)(1.8b)(102.0m)(1.6b)(1.4b)(562.0m)(3.5b)(3.0b)(4.3b)(301.0m)165.0m115.0m1.6b696.0m1.3b723.0m(1.4b)(1.6b)259.0m549.0m1.0b(327.0m)(767.0m)407.0m(79.0m)(422.0m)(13.0m)424.0m21.5b23.6b3.4b

Interest Paid

33.0m89.0m125.0m49.0m105.0m

Bristol-Myers Squibb Ratios

USDY, 2020

EV/CFO

45.2 x

Financial Leverage

2.6 x

Bristol-Myers Squibb Operating Metrics

FY, 2015FY, 2016

Phase III Trials Products

2 8

Projects in R&D Pipeline

32 44

Bristol-Myers Squibb Employee Rating

3.91940 votes
Culture & Values
4.0
Work/Life Balance
3.9
Senior Management
3.5
Salary & Benefits
4.0
Career Opportunities
3.5
Source